BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAF8.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $602,000 | +1.7% | 500,000 | 0.0% | 0.01% | 0.0% |
| Q2 2018 | $592,000 | +7.1% | 500,000 | 0.0% | 0.01% | 0.0% |
| Q1 2018 | $553,000 | -6.9% | 500,000 | 0.0% | 0.01% | -12.5% |
| Q4 2017 | $594,000 | -1.3% | 500,000 | 0.0% | 0.01% | +33.3% |
| Q3 2017 | $602,000 | +0.7% | 500,000 | 0.0% | 0.01% | 0.0% |
| Q2 2017 | $598,000 | +0.8% | 500,000 | 0.0% | 0.01% | -14.3% |
| Q1 2017 | $593,000 | +0.7% | 500,000 | 0.0% | 0.01% | -12.5% |
| Q4 2016 | $589,000 | -5.6% | 500,000 | 0.0% | 0.01% | +14.3% |
| Q3 2016 | $624,000 | +7.8% | 500,000 | 0.0% | 0.01% | +16.7% |
| Q2 2016 | $579,000 | -2.5% | 500,000 | 0.0% | 0.01% | 0.0% |
| Q1 2016 | $594,000 | -11.6% | 500,000 | 0.0% | 0.01% | 0.0% |
| Q4 2015 | $672,000 | +2.9% | 500,000 | 0.0% | 0.01% | -14.3% |
| Q3 2015 | $653,000 | -17.6% | 500,000 | 0.0% | 0.01% | +16.7% |
| Q2 2015 | $792,000 | +4.5% | 500,000 | 0.0% | 0.01% | 0.0% |
| Q1 2015 | $758,000 | +24.1% | 500,000 | 0.0% | 0.01% | 0.0% |
| Q4 2014 | $611,000 | +11.1% | 500,000 | 0.0% | 0.01% | 0.0% |
| Q3 2014 | $550,000 | +1.9% | 500,000 | 0.0% | 0.01% | 0.0% |
| Q2 2014 | $540,000 | -2.4% | 500,000 | 0.0% | 0.01% | -14.3% |
| Q1 2014 | $553,000 | +2.8% | 500,000 | 0.0% | 0.01% | -12.5% |
| Q4 2013 | $538,000 | – | 500,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|